
A simple approach to pneumococcal vaccination in adults
Author(s) -
Calvin Green,
Christine Moore,
Akhilesh Mahajan,
Kailash Bajaj
Publication year - 2018
Publication title -
journal of global infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.437
H-Index - 25
eISSN - 0974-8245
pISSN - 0974-777X
DOI - 10.4103/jgid.jgid_88_17
Subject(s) - vaccination , medicine , streptococcus pneumoniae , meningitis , otitis , pneumonia , intensive care medicine , disease , pneumococcal pneumonia , pneumococcal infections , specialty , lobar pneumonia , pneumococcal disease , pediatrics , sinusitis , immunology , family medicine , antibiotics , surgery , microbiology and biotechnology , biology
Streptococcus pneumoniae is a bacterium responsible for a spectrum of diseases including lobar pneumonia, meningitis, otitis media, and sinusitis. Invasive pneumococcal disease is responsible for significant morbidity and mortality across the world. Concerted efforts led to the development of two vaccinations, Pneumova × 23 and Prevnar 13, for the prevention of pneumococcal disease. The Advisory Committee on Immunization Practices of the US Centers for Disease Control and Prevention provides vaccination schedules for predisposed adults, but the proposed schedules remain a challenge to health-care providers. We performed a systematic review in PubMed and these specialty group websites to present the pathophysiology of pneumococcal disease, outline different pneumococcal vaccinations, and condense recommendations for vaccination administration.